Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1996 2
1997 3
1998 2
1999 1
2000 2
2002 4
2003 5
2004 7
2005 19
2006 14
2007 13
2008 20
2009 26
2010 34
2011 36
2012 75
2013 130
2014 250
2015 270
2016 283
2017 400
2018 453
2019 566
2020 761
2021 842
2022 994
2023 990
2024 563

Text availability

Article attribute

Article type

Publication date

Search Results

6,111 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Single-cell RNA sequencing of human kidney.
Liao J, Yu Z, Chen Y, Bao M, Zou C, Zhang H, Liu D, Li T, Zhang Q, Li J, Cheng J, Mo Z. Liao J, et al. Sci Data. 2020 Jan 2;7(1):4. doi: 10.1038/s41597-019-0351-8. Sci Data. 2020. PMID: 31896769 Free PMC article.
A comprehensive cellular anatomy of normal human kidney is crucial to address the cellular origins of renal disease and renal cancer. Some kidney diseases may be cell type-specific, especially renal tubular cells. ...
A comprehensive cellular anatomy of normal human kidney is crucial to address the cellular origins of renal disease and renal cancer. …
Composition and changes in breast cancer patients' diagnosis and treatment expenses under the influence of medical insurance policy reform-A study on 3 950 patients in Guangxi Medical University Cancer Hospital.
Wang C, Huang C, Zhu X. Wang C, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 May 28;46(5):521-528. doi: 10.11817/j.issn.1672-7347.2021.200525. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34148889 Free PMC article. Chinese, English.
OBJECTIVES: To understand the influence of medical insurance policy reforms in Guangxi on the hospitalization expenses of breast cancer patients by analyzing the composition and changing trend in breast cancer diagnosis and treatment expenses in the …
OBJECTIVES: To understand the influence of medical insurance policy reforms in Guangxi on the hospitalization expenses of brea …
Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis.
Qin Y, Liu Y, Xiang X, Long X, Chen Z, Huang X, Yang J, Li W. Qin Y, et al. Mol Cancer. 2023 Mar 24;22(1):59. doi: 10.1186/s12943-023-01752-8. Mol Cancer. 2023. PMID: 36959665 Free PMC article.
Recent studies suggest that cuproptosis, a novel mode of cell death, may be associated with the development of cancer. However, no studies are showing its role in tumorigenesis, progression, and prognosis. ...CS was significantly negatively correlated with tumor microenvir …
Recent studies suggest that cuproptosis, a novel mode of cell death, may be associated with the development of cancer. However, no st …
Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer.
Cao J, Xu H, Li W, Guo Z, Lin Y, Shi Y, Hu W, Ba Y, Li S, Li Z, Wang K, Wu J, He Y, Yang J, Xie C, Zhou F, Song X, Chen G, Ma W, Luo S, Chen Z, Cong M, Ma H, Zhou C, Wang W, Qi Luo, Shi Y, Qi Y, Jiang H, Guan W, Chen J, Chen J, Fang Y, Zhou L, Feng Y, Tan R, Ou J, Zhao Q, Wu J, Xin Lin, Yang L, Fu Z, Wang C, Deng L, Li T, Song C, Shi H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group, Chinese Society of Nutritional Oncology. Cao J, et al. Curr Probl Cancer. 2021 Feb;45(1):100638. doi: 10.1016/j.currproblcancer.2020.100638. Epub 2020 Aug 14. Curr Probl Cancer. 2021. PMID: 32829957 Review.
INTRODUCTION: Esophageal cancer is the fourth most common cause of cancer death in China. Patients with esophageal cancer are more likely to suffer from malnutrition. The purpose of this study is to assess nutritional status of patients with esophageal can …
INTRODUCTION: Esophageal cancer is the fourth most common cause of cancer death in China. Patients with esophageal cancer …
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.
Tang LL, Chen YP, Chen CB, Chen MY, Chen NY, Chen XZ, Du XJ, Fang WF, Feng M, Gao J, Han F, He X, Hu CS, Hu DS, Hu GY, Jiang H, Jiang W, Jin F, Lang JY, Li JG, Lin SJ, Liu X, Liu QF, Ma L, Mai HQ, Qin JY, Shen LF, Sun Y, Wang PG, Wang RS, Wang RZ, Wang XS, Wang Y, Wu H, Xia YF, Xiao SW, Yang KY, Yi JL, Zhu XD, Ma J. Tang LL, et al. Cancer Commun (Lond). 2021 Nov;41(11):1195-1227. doi: 10.1002/cac2.12218. Epub 2021 Oct 26. Cancer Commun (Lond). 2021. PMID: 34699681 Free PMC article.
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L, Shu Y, Wang C, Dai T, Mao T, Chen L, Guo Z, Liu B, Pan H, Cang S, Jiang Y, Wang J, Ye M, Chen Z, Jiang D, Lin Q, Ren W, Wang J, Wu L, Xu Y, Miao Z, Sun M, Xie C, Liu Y, Wang Q, Zhao L, Li Q, Huang C, Jiang K, Yang K, Li D, Liu Y, Zhu Z, Chen R, Jia L, Li W, Liao W, Liu HX, Ma D, Ma J, Qin Y, Shi Z, Wei Q, Xiao K, Zhang Y, Zhang Y, Chen X, Dai G, He J, Li J, Li G, Liu Y, Liu Z, Yuan X, Zhang J, Fu Z, He Y, Ju F, Liu Z, Tang P, Wang T, Wang W, Zhang J, Luo X, Tang X, May R, Feng H, Yao S, Keegan P, Xu RH, Wang F. Wang ZX, et al. Cancer Cell. 2022 Mar 14;40(3):277-288.e3. doi: 10.1016/j.ccell.2022.02.007. Epub 2022 Mar 3. Cancer Cell. 2022. PMID: 35245446 Free article. Clinical Trial.
Risk of VTE associated with PORTs and PICCs in cancer patients: A systematic review and meta-analysis.
Wang P, Soh KL, Ying Y, Liu Y, Huang X, Huang J. Wang P, et al. Thromb Res. 2022 May;213:34-42. doi: 10.1016/j.thromres.2022.02.024. Epub 2022 Mar 7. Thromb Res. 2022. PMID: 35279504 Review.
OBJECTIVE: We aimed to study the incidence of PORT-related VTE and PICC-related VTE in cancer patients by a meta-analysis. METHODS: A systematic search was performed using PubMed, Embase, Web of Science and the Cochrane Library. ...CONCLUSIONS: PORTs are associated with a …
OBJECTIVE: We aimed to study the incidence of PORT-related VTE and PICC-related VTE in cancer patients by a meta-analysis. METHODS: A …
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX, Yang XM, Liu YJ, Wu Y, Chen PH, Shi H, Wang JG, Zhou J, Lu GD. Li ZJ, et al. Acta Pharmacol Sin. 2021 Feb;42(2):301-310. doi: 10.1038/s41401-020-0478-3. Epub 2020 Jul 22. Acta Pharmacol Sin. 2021. PMID: 32699265 Free PMC article.
Sorafenib is the first-line medication for advanced hepatocellular carcinoma (HCC), but it can only extend limited survival. ...
Sorafenib is the first-line medication for advanced hepatocellular carcinoma (HCC), but it can only extend limited survival. ...
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).
Yang Y, Pan J, Wang H, Zhao Y, Qu S, Chen N, Chen X, Sun Y, He X, Hu C, Lin L, Yu Q, Wang S, Wang G, Lei F, Wen J, Yang K, Lin Z, Guo Y, Chen S, Huang X, Wu Y, Liang L, Chen C, Bai F, Ma X, Zhang Y, Leaw S, Zhang L, Fang W. Yang Y, et al. Cancer Cell. 2023 Jun 12;41(6):1061-1072.e4. doi: 10.1016/j.ccell.2023.04.014. Epub 2023 May 18. Cancer Cell. 2023. PMID: 37207654 Free article. Clinical Trial.
Checkpoint inhibitors are effective in recurrent/metastatic nasopharyngeal cancer (R/M NPC). RATIONALE-309 (NCT03924986) randomized 263 treatment-naive R/M NPC patients to tislelizumab or placebo every 3 weeks (Q3W), plus chemotherapy (Q3W for 4-6 cycles). ...
Checkpoint inhibitors are effective in recurrent/metastatic nasopharyngeal cancer (R/M NPC). RATIONALE-309 (NCT03924986) randomized 2 …
6,111 results